These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8618031)

  • 1. Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major.
    Foedinger D; Sterniczky B; Elbe A; Anhalt G; Wolff K; Rappersberger K
    J Invest Dermatol; 1996 May; 106(5):1012-6. PubMed ID: 8618031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to desmoplakin I and II in patients with erythema multiforme.
    Foedinger D; Anhalt GJ; Boecskoer B; Elbe A; Wolff K; Rappersberger K
    J Exp Med; 1995 Jan; 181(1):169-79. PubMed ID: 7807001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice.
    Foedinger D; Elbe-Bürger A; Sterniczky B; Lackner M; Horvat R; Wolff K; Rappersberger K
    J Invest Dermatol; 1998 Sep; 111(3):503-10. PubMed ID: 9740248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay for detection of peptide-specific human antidesmoplakin autoantibodies.
    Hinterhuber G; Binder M; Marquardt Y; Cauza K; Riedl E; Rappersberger K; Wolff K; Foedinger D
    Br J Dermatol; 2005 Aug; 153(2):413-6. PubMed ID: 16086758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon?
    Cozzani E; Di Zenzo G; Calabresi V; Caproni M; Schena D; Quaglino P; Marzano AV; Fabbri P; Rebora A; Parodi A
    Eur J Dermatol; 2011; 21(1):32-6. PubMed ID: 21233064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating plakin autoantibodies in a patient with erythema multiforme major: are they pathogenic or a manifestation of epitope spreading?
    Ellis E; Sidhu S
    Australas J Dermatol; 2014 Nov; 55(4):266-9. PubMed ID: 24689866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of autoantibodies to desmoplakin in a patient with oral erythema multiforme.
    Fukiwake N; Moroi Y; Urabe K; Ishii N; Hashimoto T; Furue M
    Eur J Dermatol; 2007; 17(3):238-41. PubMed ID: 17478387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema multiforme associated human autoantibodies against desmoplakin I and II.
    Johnson SM; Smoller BR; Horn TD
    J Invest Dermatol; 1999 Mar; 112(3):395-6. PubMed ID: 10084323
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
    Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
    J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris.
    Joly P; Thomine E; Gilbert D; Verdier S; Delpech A; Prost C; Lebbe C; Lauret P; Tron F
    J Invest Dermatol; 1994 Jul; 103(1):65-72. PubMed ID: 8027582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
    Zhou S; Ferguson DJ; Allen J; Wojnarowska F
    Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice.
    Saito H; Shimizu A; Tsunoda K; Amagai M; Ishiko A
    J Dermatol Sci; 2009 Aug; 55(2):108-15. PubMed ID: 19525093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus vulgaris with autoantibodies to desmoplakin.
    Kim SC; Chung YL; Kim J; Cho NJ; Amagai M
    Br J Dermatol; 2001 Nov; 145(5):838-40. PubMed ID: 11736914
    [No Abstract]   [Full Text] [Related]  

  • 14. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
    Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
    Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Amagai M; Nishikawa T
    J Invest Dermatol; 2004 May; 122(5):1145-53. PubMed ID: 15140217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern-Specific Loss of Desmoplakin I and II Immunoreactivity in Erythema Multiforme and its Variants: A Possible Aid in Histologic Diagnosis.
    Forrester VJ; Tran B; Hein SC; Wick MR
    Am J Dermatopathol; 2020 Feb; 42(2):111-116. PubMed ID: 31599750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human autoantibodies against desmoplakins in paraneoplastic pemphigus.
    Oursler JR; Labib RS; Ariss-Abdo L; Burke T; O'Keefe EJ; Anhalt GJ
    J Clin Invest; 1992 Jun; 89(6):1775-82. PubMed ID: 1601988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalization via plasmalemmal vesicles: a route for antidesmoplakin autoantibodies into cultured human keratinocytes.
    Cauza K; Hinterhuber G; Mann U; Horvat R; Rappersberger K; Wolff K; Foedinger D
    Exp Dermatol; 2003 Oct; 12(5):546-54. PubMed ID: 14705794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients.
    Eyre RW; Stanley JR
    J Exp Med; 1987 Jun; 165(6):1719-24. PubMed ID: 2438368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A complementarity-determining region peptide of an anti-desmosome autoantibody may interact with the desmosomal plaque through molecular mimicry with a cytoplasmic desmoglein 1 sequence.
    Gilbert D; Courville P; Brard F; Joly P; Petit S; Bernardi E; Schoofs AR; Lauret P; Tron F
    Eur J Immunol; 1997 May; 27(5):1055-60. PubMed ID: 9174592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.